Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Volpi

Showing results (71-80 of 203) with videos related to

Pageof 21
Sort By:
Clinical Endocrinology|December 3, 1999
Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjectsV Coiro, R Volpi, L Capretti, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1984
Failure of naloxone to modify anterior pituitary secretory pattern in insulin-dependent diabeticsP Chiodera, R Volpi, V Coiro, et al.
Journal of Internal Medicine|August 11, 1998
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabeticsR Volpi, P Chiodera, L Capretti, et al.
Fertility and Sterility|April 1, 1987
Oxytocin enhances thyrotropin-releasing hormone-induced prolactin release in normal menstruating womenV Coiro, A Gnudi, R Volpi, et al.
Clinical Endocrinology|November 28, 1997
Influence of residual C-peptide secretion on nocturnal serum TSH peak in well-controlled diabetic patientsV Coiro, R Volpi, C Marchesi, et al.
La Medicina Del Lavoro|March 1, 1988
[Increased urinary excretion of D-glucaric acid in workers exposed to styrene in reinforced plastics industry]R Volpi, F Bauleo, R Pasquini, et al.
Neuroendocrinology|June 1, 1992
Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrierP Chiodera, R Volpi, L Capretti, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 29, 2000
Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRHV Coiro, R Volpi, S Cataldo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1984
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanismP Chiodera, V Coiro, G Speroni, et al.
Metabolism: Clinical and Experimental|August 1, 1989
Naloxone abolishes the inhibiting effect of somatostatin on the release of oxytocin evoked by insulin-induced hypoglycemia in humansP Chiodera, A Gnudi, L Bianconi, et al.
Pageof 21

Showing results (71-80 of 203) with videos related to

Sort By:
Pageof 21
Clinical Endocrinology|December 3, 1999
Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjectsV Coiro, R Volpi, L Capretti, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1984
Failure of naloxone to modify anterior pituitary secretory pattern in insulin-dependent diabeticsP Chiodera, R Volpi, V Coiro, et al.
Journal of Internal Medicine|August 11, 1998
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabeticsR Volpi, P Chiodera, L Capretti, et al.
Fertility and Sterility|April 1, 1987
Oxytocin enhances thyrotropin-releasing hormone-induced prolactin release in normal menstruating womenV Coiro, A Gnudi, R Volpi, et al.
Clinical Endocrinology|November 28, 1997
Influence of residual C-peptide secretion on nocturnal serum TSH peak in well-controlled diabetic patientsV Coiro, R Volpi, C Marchesi, et al.
La Medicina Del Lavoro|March 1, 1988
[Increased urinary excretion of D-glucaric acid in workers exposed to styrene in reinforced plastics industry]R Volpi, F Bauleo, R Pasquini, et al.
Neuroendocrinology|June 1, 1992
Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrierP Chiodera, R Volpi, L Capretti, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 29, 2000
Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRHV Coiro, R Volpi, S Cataldo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1984
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanismP Chiodera, V Coiro, G Speroni, et al.
Metabolism: Clinical and Experimental|August 1, 1989
Naloxone abolishes the inhibiting effect of somatostatin on the release of oxytocin evoked by insulin-induced hypoglycemia in humansP Chiodera, A Gnudi, L Bianconi, et al.
Pageof 21